Drug Type Small molecule drug |
Synonyms Compound 21b(Yantai University) |
Target |
Action agonists |
Mechanism 5-HT2C receptor agonists(Serotonin 2c (5-HT2c) receptor agonists), TAAR1 agonists(Trace amine-associated receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC10H14N2S |
InChIKeyGDYQHGUKSUFMKC-SECBINFHSA-N |
CAS Registry3024777-80-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | China | 31 Mar 2025 | |
Schizophrenia | Preclinical | China | 31 Mar 2025 |